FindTrial
Sign In

A phase 3 clinical trial of duloxetine in patients with chronic low back pain

A phase 3 clinical trial of duloxetine in patients with chronic low back pain

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222083
Enrollment
Unknown
Registered
2013-05-15
Start date
2013-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain

Interventions

investigational material(s) Generic name etc : LY248686 INN of investigational material : Duloxetine Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administra

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor
Eli Lilly and Company
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants with chronic low back pain present on 6 months or longer. And et al.

Exclusion criteria

Exclusion criteria: Participants with past history of multiple episodes of drug allergy. Participants previously treated with duloxetine. And et al.

Design outcomes

Primary

MeasureTime frame
Change from baseline in Brief Pain Inventory (BPI)-average pain score—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026